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Splanchnic vein thrombosis is a well-recognized complication of
acute and chronic pancreatitis but little is known about the exact
incidence, clinical relevance and optimal treatment strategy. In
this issue of HPB, two new studies1,2 have shed new light on this
complication. In a systematic literature review, Butler et al. from
Indianapolis described a pooled incidence of pancreatitis-induced
splenic vein thrombosis of 23% in acute pancreatitis and 12% in
chronic pancreatitis.1 Only half the patients with splenic vein
thrombosis developed splenomegaly and 12% experienced gas-
trointestinal bleeding. Gonzelez et al. from London also described
a series of 127 patients with acute pancreatitis of whom 20
patients (15%) developed splanchnic vein thrombosis.2
Of all patients presenting with pancreatitis, 80–85% suffer a
self-limiting disease without pancreatic necrosis or collections
and hence are very unlikely to develop venous thrombosis. There-
fore, the incidence of 15–23% from the aforementioned studies
would appear to be an overestimate and suggest that all patients
with severe acute pancreatitis develop splenic or splanchnic vein
thrombosis. When looking in more detail at the two studies, the
reasons for the reported high incidences become clear. First, the
systematic review1 included 52 case reports of splenic vein throm-
bosis, thus increasing the incidence. Additionally, as noted by
Butler et al.,1 the incidence will be significantly affected by time as
a result of the changing use and accuracy of cross-sectional
imaging over the past two decades. Second, in the study by Gon-
zelez et al.,2 all 20 patients with splanchnic vein thrombosis were
tertiary referrals. Furthermore, 19 of these 20 patients had peri-
pancreatic collections clearly supporting the notion that splanch-
nic vein thrombosis is a complication of severe and not mild
pancreatitis.2 It seems fair to conclude that the high incidences do
not reflect the ‘true’ incidence of splanchnic or splenic vein
thrombosis that would be found in an unselected series of patients
with acute pancreatitis.
Nonetheless, it can be assumed that in a tertiary referral centre
for patients with severe acute pancreatitis, this complication will
be encountered frequently. The increased recognition coincides
with an increasing clinical relevance. As the optimal indications
and interventions are acknowledged for infected necrotizing pan-
creatitis,3,4 identifying pre-operatively the presence of splenom-
egaly, major collaterals or varices which may impede a left-sided
minimally invasive approach is crucial. In the presence of sple-
nomegaly, the retroperitoneal window between the spleen and
kidney may be reduced significantly thus preventing a left-sided
approach to the infected necrosis.3 Similarly, any varices travers-
ing this window should be avoided to prevent the potential for
haemorrhage upon dilatation of the retroperitoneal tract.3 In the
era of endoscopic or laparoscopic approaches to walled-off
necrosis, recognizing the presence of gastric or left-sided sinus-
tral hypertension is vital if a catastrophic haemorrhage is to be
avoided. Thus in the presence of significant gastric varices
between the necrosis and the gastric lumen an infracolic
approach via the avascular window of the left transverse meso-
colon may be a safer option. The importance of a surgical-
induced haemorrhage after necrosectomy should not be under
estimated as it has been shown to be a significant independent
predictor of mortality.5 Unlike arterial bleeding, which can
usually be controlled by radiological embolization, variceal
bleeding from the pancreatic bed can be more problematic.5
Techniques such as porto-systemic shunts, splanchnic vasocon-
strictors or a tamponade used to control a haemorrhage from
portal hypertension in patients with cirrhosis would appear to
offer little in the patient with severe acute pancreatitis. In the
setting of gastointestinal bleeding related to splenic venous
thrombosis a highly effective treatment is a splenectomy.6 In
complicated situations, a two-step procedure has been described
involving splenic artery embolization followed by delayed a sple-
nectomy.6 In patients unfit for surgery, embolization could be the
sole treatment.6
Ascites from extensive splanchnic thrombosis is a further con-
cerning symptom and although based on case reports2,5 would
appear to be associated with significant morbidity and mortality.
For this reason, at least one author2 recommends anticoagulation
DOI:10.1111/j.1477-2574.2011.00411.x HPB
HPB 2011, 13, 831–832 © 2011 International Hepato-Pancreato-Biliary Association
in this setting or if there is propagation of thrombosis into the
main or intra-hepatic portal vein.2
Given the likelihood that the majority of patients with splenic
vein thrombosis will be asymptomatic1 and the reported spon-
taneous recanalization rate is 30%,2 it would seem sensible to
reserve anticoagulation therapy for patients with progression of
thrombosis; however, the evidence base for this remains poor. It
would seem important to try and identify those who are at a
higher risk of bleeding particularly if anticoagulation is being
considered. Careful attention to the drainage of the coronary
vein may help select those at an increased risk of oesophageal
varices.1 Routine endoscopy, which is the gold standard to iden-
tify oesophageal varices, should also be considered.1 It should
also be appreciated that splenomegaly is not present in all
patients with splenic vein thrombosis and hence not a reliable
marker of sinustral hypertension.1 Thought should also be given
to the presence of cirrhosis which may contribute to portal
hypertension and be associated with an increased risk of
bleeding.1
In the future, the use of complete, large, multicentre, collabo-
rative research databases4 will be required to determine the true
significance of this increasingly recognized complication. Most
importantly, identifying prognostic factors that then allow those
patients at high risk of further complications to be concentrated
into appropriately designed treatment studies will be needed if the
outcome associated with this severe illness is to be improved.
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